Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
The dysregulation of chromatin and epigenetics has been defined as the overarching cancer hallmark. By disrupting transcriptional regulation in normal cells and mediating tumor progression by promoting cancer cell plasticity, this process has the ability to mediate all defined hallmarks of cancer. I...
Main Authors: | Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, Joonas Uusi-Makela, Kirsi J. Granberg, Matti Nykter, Alfonso Urbanucci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3325 |
Similar Items
-
A Method to Study the Epigenetic Chromatin States of Rare Hematopoietic Stem and Progenitor Cells; MiniChIP–Chip
by: Weishaupt Holger, et al.
Published: (2010-05-01) -
A Method to Study the Epigenetic Chromatin States of Rare Hematopoietic Stem and Progenitor Cells; MiniChIP–Chip
by: Weishaupt Holger, et al.
Published: (2010-01-01) -
Chromatin regulators: weaving epigenetic nets
by: Hernández-Muñoz Inmaculada
Published: (2010-10-01) -
Differential regulation of lineage commitment in human and mouse primed pluripotent stem cells by the nucleosome remodelling and deacetylation complex
by: Ramy Ragheb, et al.
Published: (2020-07-01) -
FBXL19 recruits CDK-Mediator to CpG islands of developmental genes priming them for activation during lineage commitment
by: Emilia Dimitrova, et al.
Published: (2018-05-01)